Mehmet Sinan Dal

12PUBLICATIONS
178CO-AUTHORS
Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Te urupare me te whai wāhi Māori ki te mātauranga (Māori responsiveness and engaged education)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 29, 2025
Pulmonary Embolism in Hematologic Malignancies: Predictive Value of the D-Dimer/Albumin Ratio and Proposal of the Hema-PE Score.

Esma Sevil Akkurt, Ozlem Duvenci Birben, Mehmet Hakan Akbulut

|Apr 13, 2025
Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias.

Abdullah Karakus, Tayfur Toptas, Mehmet Sinan Dal

|Nov 06, 2024
Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis

Ünal Ataş, Ozan Salim, Utku Iltar

|Sep 13, 2024
A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients.

Özgür Mehtap, Tayfur Toptas, Mehmet S Dal

|Nov 14, 2023
Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye

Atakan Tekinalp, Ayfer Gedük, Aydan Akdeniz

|Nov 19, 2022
Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey.

Mehmet Sinan Dal, Bahar Uncu Ulu, Ant Uzay

Pageof 2

Frequent Collaborators

6 joint publications

Fevzi Altuntaş

4 joint publications

Tuğçe Nur Yiğenoğlu

4 joint publications

Bahar Uncu Ulu

3 joint publications

Özgür Mehtap